Response of low-grade oligodendroglial tumors to temozolomide.

Suppr

超能文献

作者信息

Byrne Thomas N

机构信息

Neurosurgery and Internal Medicine, Yale University School of Medicine, USA.

出版信息

J Neurooncol. 2004 Dec;70(3):279-80. doi: 10.1007/s11060-004-5896-4.

DOI:10.1007/s11060-004-5896-4

PMID:15662968

Abstract

摘要

相似文献

Response of low-grade oligodendroglial tumors to temozolomide.

J Neurooncol. 2004 Dec;70(3):279-80. doi: 10.1007/s11060-004-5896-4.

Impact of chromosome 1p status in response of oligodendroglioma to temozolomide: preliminary results.

J Neurooncol. 2003 Feb;61(3):267-73. doi: 10.1023/a:1022580610598.

Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions.

J Clin Oncol. 2004 Aug 1;22(15):3133-8. doi: 10.1200/JCO.2004.10.169.

Progressive low-grade oligodendrogliomas: response to temozolomide and correlation between genetic profile and O6-methylguanine DNA methyltransferase protein expression.

Cancer. 2006 Apr 15;106(8):1759-65. doi: 10.1002/cncr.21809.

Salvage PCV chemotherapy for temozolomide-resistant oligodendrogliomas.

Neurology. 2004 Sep 14;63(5):904-6. doi: 10.1212/01.wnl.0000137049.65631.db.

1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment.

Eur J Cancer. 2006 Oct;42(15):2499-503. doi: 10.1016/j.ejca.2006.05.021. Epub 2006 Aug 17.

Temozolomide single-agent chemotherapy for newly diagnosed anaplastic oligodendroglioma.

J Neurooncol. 2009 Mar;92(1):57-63. doi: 10.1007/s11060-008-9735-x. Epub 2008 Nov 15.

Efficacy and patient-reported outcomes with dose-intense temozolomide in patients with newly diagnosed pure and mixed anaplastic oligodendroglioma: a phase II multicenter study.

J Neurooncol. 2015 Mar;122(1):111-9. doi: 10.1007/s11060-014-1684-y. Epub 2014 Dec 23.

Complete durable response of a pediatric anaplastic oligodendroglioma to temozolomide alone: Case report and review of literature.

Pediatr Blood Cancer. 2017 Dec;64(12). doi: 10.1002/pbc.26708. Epub 2017 Jul 11.

Temozolomide treatment of refractory epilepsy in a patient with an oligodendroglioma.

Epilepsia. 2006 Jul;47(7):1237-8. doi: 10.1111/j.1528-1167.2006.00597.x.

引用本文的文献

Predicting the outcome of grade II glioma treated with temozolomide using proton magnetic resonance spectroscopy.

Br J Cancer. 2011 Jun 7;104(12):1854-61. doi: 10.1038/bjc.2011.174. Epub 2011 May 24.

Toxicity and efficacy of protracted low dose temozolomide for the treatment of low grade gliomas.

J Neurooncol. 2007 May;82(3):281-8. doi: 10.1007/s11060-006-9280-4. Epub 2006 Nov 3.

Preoperative estimation of residual volume for WHO grade II glioma resected with intraoperative functional mapping.

Neuro Oncol. 2007 Jan;9(1):63-9. doi: 10.1215/15228517-2006-015. Epub 2006 Oct 3.

本文引用的文献

Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions.

J Clin Oncol. 2004 Aug 1;22(15):3133-8. doi: 10.1200/JCO.2004.10.169.

Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971.

J Clin Oncol. 2003 Jul 1;21(13):2525-8. doi: 10.1200/JCO.2003.12.015.

Phase II trial of temozolomide in patients with progressive low-grade glioma.

J Clin Oncol. 2003 Feb 15;21(4):646-51. doi: 10.1200/JCO.2003.01.009.

Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities.

J Clin Oncol. 2003 Jan 15;21(2):251-5. doi: 10.1200/JCO.2003.06.023.

Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapy.

J Clin Oncol. 2001 May 1;19(9):2449-55. doi: 10.1200/JCO.2001.19.9.2449.

Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis.

Clin Cancer Res. 2001 Apr;7(4):839-45.

Long-term outcome of low-grade oligodendroglioma and mixed glioma.

Neurology. 2000 Apr 11;54(7):1442-8. doi: 10.1212/wnl.54.7.1442.

Neoadjuvant procarbazine, CCNU, and vincristine for anaplastic and aggressive oligodendroglioma.

Neurology. 1999 Sep 22;53(5):1141-3. doi: 10.1212/wnl.53.5.1141.

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.

J Natl Cancer Inst. 1998 Oct 7;90(19):1473-9. doi: 10.1093/jnci/90.19.1473.

Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group.

J Clin Oncol. 1994 Oct;12(10):2013-21. doi: 10.1200/JCO.1994.12.10.2013.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验